US investor takes stake in Sensyne Health

Sensyne Health CEO Paul Drayson
Paul Drayson, CEO, Sensyne Health

Nasdaq-listed technology investor Acacia Research Corporation has acquired an 11.8% stake in UK-based clinical AI company Sensyne Health. Precise terms of the deal have not been disclosed, but it forms part of an agreement to purchase shares in up to 19 public and private life sciences companies from LF Equity Income Fund for £223.9m. Founded…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »